Equities

CM Hospitalar SA

VVEO3:SAO

CM Hospitalar SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (BRL)2.85
  • Today's Change0.09 / 3.26%
  • Shares traded0.00
  • 1 Year change-83.33%
  • Beta--
Data delayed at least 15 minutes, as of Jun 01 2024 00:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.

  • Revenue in BRL (TTM)11.24bn
  • Net income in BRL326.07m
  • Incorporated2010
  • Employees7.00k
  • Location
    CM Hospitalar SAAvenida Luiz Maggionin 2.727, Distrito EmpresarialRIBEIRAO PRETO 14.072-055BrazilBRA
  • Phone+55 1 121028081
  • Websitehttps://ri.viveo.com.br/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pharmaniaga Berhad3.79bn-86.31m578.16m3.78k------0.1524-0.0572-0.05722.55-0.20561.824.599.57---4.06-6.88---38.459.046.64-2.23-3.660.27621.371.29---3.027.3887.25--23.35--
Sopharma Trading AD5.04bn91.75m583.33m2.73k6.361.473.130.11580.92010.920150.503.982.660.15867.16661,702.604.852.3914.877.8897.9898.091.821.010.6231185.950.6107--13.0213.26221.6727.863.70--
Profarma Distribuidora de Produts Frm SA8.89bn77.11m652.49m7.08k8.380.51512.730.07340.62890.628972.5010.231.774.677.67--1.701.644.063.4014.9714.610.96180.95190.76961.850.4552--10.8215.19-12.95--41.08--
Charmacy Pharmaceutical Co Ltd3.19bn37.23m678.85m831.0018.231.5712.030.21260.51390.513944.075.981.446.054.885,728,231.001.681.798.287.996.346.081.171.240.77752.790.511137.095.472.27-43.252.48-16.010.0027
EQL Pharma AB131.62m11.31m761.66m21.0068.838.60--5.790.76420.76428.886.120.80121.744.8012,579,430.006.899.0211.9015.2743.5537.958.598.290.56948.880.4032--1.6439.64-26.57--32.73--
Hemas Holdings PLC2.11bn106.13m901.87m5.83k8.501.206.460.426910.2410.24203.8572.791.273.334.7020,874,320.006.615.7112.5110.4129.6029.365.234.941.015.010.223628.306.7413.6743.1012.64-2.3313.12
CM Hospitalar SA11.24bn326.07m936.18m7.00k2.800.28111.560.08331.041.0436.9310.321.125.564.671,606,019.003.254.004.516.1515.1315.892.903.501.681.560.576--26.7233.2238.5760.22-2.72--
Salus Ljubljana dd3.55bn65.44m1.20bn144.0018.352.7111.490.338108.99108.995,902.00738.122.9510.397.61--5.446.5912.5213.6410.458.501.852.280.816518.490.210760.7320.9318.82-20.5819.3769.2413.60
Shanghai Kai Kai Industrial Co Ltd695.20m38.22m1.29bn492.0043.473.71--1.850.21720.21723.952.550.781910.683.501,950,902.004.492.396.983.5318.6323.545.743.201.28--0.035526.333.461.06-1.572.2134.011.72
TTK Healthcare Ltd473.15m39.50m1.32bn1.29k33.302.0927.582.7844.4844.48532.85708.350.63513.738.43--5.305.066.407.0255.0754.718.355.475.018.810.022331.473.823.7040.6920.8619.1214.87
Data as of Jun 01 2024. Currency figures normalised to CM Hospitalar SA's reporting currency: Brazilian Real BRL

Institutional shareholders

22.63%Per cent of shares held by top holders
HolderShares% Held
GIC Pte Ltd. (Investment Management)as of 10 Jan 202328.62m8.87%
Dynamo Administra��o de Recursos Ltda.as of 12 Apr 202315.79m4.89%
Verde Asset Management SAas of 31 Jan 20247.50m2.32%
The Vanguard Group, Inc.as of 09 May 20245.63m1.74%
BTG Pactual WM Gest�o de Recursos Ltda.as of 31 Jan 20243.70m1.15%
Nucleo Capital Ltda.as of 30 Apr 20233.54m1.10%
Fidelity Management & Research Co. LLCas of 31 Mar 20243.21m1.00%
BlackRock Brasil Gestora de Investimentos Ltda.as of 09 May 20242.44m0.76%
Velt Partners Investimentos Ltdaas of 30 Apr 20231.59m0.49%
Sharp Capital Gestora de Recursos Ltda.as of 31 Jan 20241.03m0.32%
More ▼
Data from 30 Sep 2023 - 20 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.